PR Newswire

Cision is a leading global provider of earned media software. Cision PR Newswire empowers communicators to identify influencers, craft campaigns and attribute value from the broadest spectrum of media sources, allowing them to create meaningful stories and measure the impact.
Results: 3385-3396 of 41453

Pierre Fabre Laboratories receives CHMP positive opinion for BRAFTOVI® (encorafenib) in combination with cetuximab and FOLFOX (fluorouracil, leucovorin, and oxaliplatin) for the first-line treatment of adult patients with BRAFV600E-mutant metastatic colorectal cancer (mCRC)







